Vertex Pharmaceuticals price target raised to $545 from $520 at BMO Capital
BMO Capital analyst Evan Seigerman raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $545 from $520 and keeps an Outperform ...
MarketWatch21h
Howmet Aerospace Inc.
Berkshire Hathaway Inc. Cl A 2.50% $998.73B Berkshire Hathaway Inc. Cl B 2.48% $998.73B ...
Business Insider18h
U.S. Global Technology and Aerospace & Defense ETF
Historical Prices for U.S. Global Technology and Aerospace & Defense ETF Loading.. Sustainability Rating Investment Policy Indices Commodities Currencies Stocks ...